These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12189559)

  • 1. COX-2 selective inhibition reverses the trophic properties of gastrin in colorectal cancer.
    Yao M; Song DH; Rana B; Wolfe MM
    Br J Cancer; 2002 Aug; 87(5):574-9. PubMed ID: 12189559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer.
    Connolly EM; Harmey JH; O'Grady T; Foley D; Roche-Nagle G; Kay E; Bouchier-Hayes DJ
    Br J Cancer; 2002 Jul; 87(2):231-7. PubMed ID: 12107848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor.
    Zhang Z; DuBois RN
    Oncogene; 2001 Jul; 20(33):4450-6. PubMed ID: 11494140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 inhibitor NS-398 suppresses cell growth and constitutive production of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells.
    Nakata H; Uemura Y; Kobayashi M; Harada R; Taguchi H
    Cancer Sci; 2003 Feb; 94(2):173-80. PubMed ID: 12708493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
    Abdalla SI; Lao-Sirieix P; Novelli MR; Lovat LB; Sanderson IR; Fitzgerald RC
    Clin Cancer Res; 2004 Jul; 10(14):4784-92. PubMed ID: 15269153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.
    Elder DJ; Halton DE; Hague A; Paraskeva C
    Clin Cancer Res; 1997 Oct; 3(10):1679-83. PubMed ID: 9815550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer.
    Yao M; Lam EC; Kelly CR; Zhou W; Wolfe MM
    Br J Cancer; 2004 Feb; 90(3):712-9. PubMed ID: 14760389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycine-extended gastrin stimulates proliferation and inhibits apoptosis in colon cancer cells via cyclo-oxygenase-independent pathways.
    Ogunwobi OO; Beales IL
    Regul Pept; 2006 Mar; 134(1):1-8. PubMed ID: 16169610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate.
    Crew TE; Elder DJ; Paraskeva C
    Carcinogenesis; 2000 Jan; 21(1):69-77. PubMed ID: 10607736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrin promotes human colon cancer cell growth via CCK-2 receptor-mediated cyclooxygenase-2 induction and prostaglandin E2 production.
    Colucci R; Blandizzi C; Tanini M; Vassalle C; Breschi MC; Del Tacca M
    Br J Pharmacol; 2005 Feb; 144(3):338-48. PubMed ID: 15655524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of cyclooxygenase (COX)-2 products in acceleration of ulcer healing by gastrin and hepatocyte growth factor.
    Brzozowski T; Konturek PC; Konturek SJ; Pajdo R; Schuppan D; Drozdowicz D; Ptak A; Pawlik M; Nakamura T; Hahn EG
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):751-73. PubMed ID: 11192947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrin enhances gastric mucosal integrity through cyclooxygenase-2 upregulation in rats.
    Komori M; Tsuji S; Sun WH; Tsujii M; Kawai N; Yasumaru M; Kakiuchi Y; Kimura A; Sasaki Y; Higashiyama S; Kawano S; Hori M
    Am J Physiol Gastrointest Liver Physiol; 2002 Dec; 283(6):G1368-78. PubMed ID: 12388195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
    Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN
    Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines.
    Cheng J; Imanishi H; Amuro Y; Hada T
    Int J Cancer; 2002 Jun; 99(5):755-61. PubMed ID: 12115513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
    Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM
    J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
    Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
    FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms involved in the antiproliferative effect of two COX-2 inhibitors, nimesulide and NS-398, on colorectal cancer cell lines.
    Buecher B; Broquet A; Bouancheau D; Heymann MF; Jany A; Denis MG; Bonnet C; Galmiche JP; Blottière HM
    Dig Liver Dis; 2003 Aug; 35(8):557-65. PubMed ID: 14567460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent modulation of apoptosis and cyclooxygenase-2 expression in human 1547 osteosarcoma cells by NS-398, a selective cyclooxygenase-2 inhibitor.
    Moalic S; Liagre B; Le Bail JC; Beneytout JL
    Int J Oncol; 2001 Mar; 18(3):533-40. PubMed ID: 11179483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
    Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.